To build trust, health insurers need to demonstrate their value to customers. That means offering a convenient, satisfying customer experience. Here’s how.
As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.
These technology solutions on the market can treat chronic pain, allowing patients to eliminate or decrease their dependence on opioid drugs.
Payers are becoming more receptive to a different approach for paying for addiction treatment and recovery services, as evidenced by the formation of a new healthcare alliance that aims to redesign the structure and payment of these services.
If all consumers had a high understanding of how to navigate the healthcare system, health insurers could save billions of dollars a year. Here’s what you should do.
Here’s how healthcare can do more to help patients learn more about their health to better prepare them to participate in their own treatment.
Glucose monitoring technology could become the go-to management strategy in a few years. Here’s where we are and where we are going.
Payers struggle to determine the appropriate criteria for covering innovative treatments and providers want to increase patient access. Patients’ lives can hang in the balance.
NORC at the University of Chicago set out to understand more Americans’ experiences with surprise billing. You won’t believe what they found.
A new study on the overlap between the causes of rheumatoid arthritis and Huntington’s disease opens up new therapeutic targets and drugs for both conditions.